Andrew Sharpe

USPTO Granted Patents = 28 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 12)

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 162(Granted Patents)

Location History:

Slough, GB (2012)
Saffron Walden Essex, GB (2014 - 2019)
Saffron Walden, GB (1996 - 2020)
Cambridge, GB (2000 - 2021)

Company Filing History:

8 out of 90

Darwin Discovery Limited

Kabushiki Kaisha Toshiba

Bnos Electronics Limited

patents

6. 2 out of 230

Glaxosmithkline Intellectual Property Development Limited

F. Hoffmann-la Roche Ag

patents

Years Active: 1996-2021

Loading Chart...

28 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11177409 - On-chip integration of MMIC and single photon detectors (2021-11-16),

2. 10793559 - Chemical compounds (2020-10-06),

3. 10680130 - On-chip integration of MMIC and single photon detectors (2020-06-09),

4. 10457674 - Chemical compounds (2019-10-29),

5. 10214509 - Amino-substituted heterocyclic derivatives as sodium channel inhibitors (2019-02-26),

6. 10130619 - Amido thiadiazole derivatives as NADPH oxidase inhibitors (2018-11-20),

7. 9931323 - Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2018-04-03),

8. 9505746 - Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2016-11-29),

9. 9328106 - Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2016-05-03),

10. 8785628 - Triazine derivatives as kinase inhibitors (2014-07-22),

11. 8755687 - Communication system and method (2014-06-17),

12. 8653105 - Quinoline derivatives as kinase inhibitors (2014-02-18),

13. 8637543 - Quinoline derivatives as kinase inhibitors (2014-01-28),

14. 8614206 - Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2013-12-24),

15. 8513284 - Fused pyridine and pyrazine derivatives as kinase inhibitors (2013-08-20),

Title: Andrew Sharpe: Innovating in Photon Detection and Chemical Compounds

Introduction: Andrew Sharpe, a prolific inventor based in Saffron Walden, GB, has made significant contributions to the fields of photon detection devices and chemical compounds. With an impressive portfolio of 28 patents, his work has been instrumental in advancing technology and scientific research.

Latest Patents:

1. In his latest patent, Andrew Sharpe introduced the concept of on-chip integration of MMIC and single photon detectors, revolutionizing photon detection devices. This innovation involves a method of fabricating a photon detection device that combines AC and DC input voltages to detect single photons with exceptional precision.

2. Another notable patent by Andrew Sharpe focuses on chemical compounds that inhibit kinase activity, particularly PI3-kinase activity. These novel compounds, represented by formula (I) and its salts, have shown promising potential in the field of medical research and drug development.

Career Highlights:

Throughout his career, Andrew Sharpe has showcased a remarkable talent for innovation and problem-solving. His patents reflect a deep understanding of complex technologies and a dedication to pushing the boundaries of scientific discovery. Sharpe has not only secured patents but has also actively contributed to the practical application of his inventions.

Collaborations:

Andrew Sharpe has collaborated with esteemed professionals in his field, including Alan Findlay Haughan and Hazel Joan Dyke. Together, they have leveraged their expertise to develop cutting-edge solutions and drive forward advancements in photon detection and chemical compound research.

Conclusion:

In conclusion, Andrew Sharpe stands out as a visionary inventor whose work has left a lasting impact on the fields of photon detection and chemical compounds. His innovative spirit, coupled with a strong scientific acumen, continues to drive progress and inspire future generations of inventors in the ever-evolving landscape of technology and research.

This text is generated by artificial intelligence and may not be accurate.